Équilibre Biopharmaceuticals Corp. was established as an innovative biopharmaceutical company focused on identifying and developing high-potential drugs for patients who are treatment-resistant or unresponsive to other existing medications. 

Biotechnology

Équilibre Biopharmaceuticals

Philip A. Barach

Sumera Younis

Bijan Bayat

Julie Seiffert

Kevin McCracken

Alexandra Zanin-Zhorov

Justin Stebbing

Amy Melsaether

Meg Dodge

Debra Maierhofer

Christopher Thorn

Steven Gordon

Leadership Team

Advisory Team

Corporate Strategy and Operations Team

Regulatory and Compliance Team

Teams at Équilibre Biopharmaceuticals

Leadership Team

Advisory Team

Corporate Strategy and Operations Team

Regulatory and Compliance Team